Print this page

Observations placeholder

Neupogen

Identifier

019684

Type of spiritual experience

Hallucination (73)

A description of the experience

Filgrastim is a granulocyte colony-stimulating factor (G-CSF) analog used to stimulate the proliferation and differentiation of granulocytes; it is a pharmaceutical analog of naturally occurring G-CSF. It is produced by recombinant DNA technology. The gene for human granulocyte colony-stimulating factor is inserted into the genetic material of Escherichia coli. The G-CSF then produced by E. coli is different from G-CSF naturally made in humans. Amgen originally licensed filgrastim (trade name Neupogen) in 1991.

Neupogen (filgrastim) is a man-made form of a protein that stimulates the growth of white blood cells in your body. White blood cells help your body fight against infection.  Neupogen is used to treat neutropenia, a lack of certain white blood cells caused by cancer, bone marrow transplant, receiving chemotherapy, or by other conditions.  Neupogen may also be used for purposes not listed in this medication guide.

Adverse effects

The most commonly observed adverse effect is mild bone pain after repeated administration and local skin reactions at the site of injection Other observed adverse effects include serious allergic reactions (including a rash over the whole body, shortness of breath, wheezing, dizziness, swelling around the mouth or eyes, fast pulse, and sweating), ruptured spleen (sometimes resulting in death), alveolar hemorrhage, acute respiratory distress syndrome, and hemoptysis. Severe sickle cell crises, in some cases resulting in death, have been associated with the use of filgrastim in patients with sickle cell disorders.

 

On Jan, 21, 2016: 13,564 people reported to have side effects when taking Neupogen. Among them, 73 people (0.54%) have Hallucination.

Time on Neupogen when people have Hallucination :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Hallucination 40.00% 60.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Gender of people who have Hallucination when taking Neupogen  :

  Female Male
Hallucination 69.86% 30.14%

Age of people who have Hallucination when taking Neupogen  :

  0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Hallucination 0.00% 3.12% 10.94% 7.81% 43.75% 3.12% 15.62% 15.62%

 

 

On Jan, 17, 2016: 13,564 people reported to have side effects when taking Neupogen. Among them, 438 people (3.23%) have Death.

Time on Neupogen when people have Death  :

  < 1 month 1 - 6 months 6 - 12 months 1 - 2 years 2 - 5 years 5 - 10 years 10+ years
Death 80.00% 11.76% 3.53% 3.53% 0.00% 1.18% 0.00%

Gender of people who have Death when taking Neupogen  :

  Female Male
Death 36.67% 63.33%

Age of people who have Death when taking Neupogen  :

  0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Death 0.00% 0.71% 4.63% 2.14% 3.20% 8.90% 16.01% 64.41%

 

 

The source of the experience

eHealthme

Activities

Observation contributed by: Julie Usher